SAGE Therapeutics (SAGE), Biogen (BIIB) to Submit NDA for Zuranolone to FDA in Second Half of 2022 with Rolling Submission Expected to Start in Early 2022
- Wall Street drops as bargain-hunting loses steam
- Netflix (NFLX) Stock Tanks 19% on Paid Net Additions Miss & Lower Guidance
- Peloton (PTON) Warns for Q2 But Stock Rallies After-Hours as Worst Case Avoided
- Morgan Stanley Sees Apple (AAPL) Beating December Quarter Views But Says Upside Largely Priced In
- Ford (F) Stock Extends Losses in Pre Market as Jefferies Downgrades to Hold, Analyst Says Stock is 'Missing a New Angle'